Who
Mark E. Delaney
SVP & Chief Commercial Officer
Company insider
Files Form 4 as: SVP & Chief Commercial Officer, Quest Diagnostics.
In numbers
- Trades disclosed
- 51
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $2.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 23 Feb 2023
- Last trade
- 28 Jul 2026
- Last filed
- 29 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 29 Jul 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $376K1,600 at $235.18 | filing |
| 28 Jul 2026filed 29 Jul 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $376K1,600 at $235.18 | filing |
| 22 Jul 2026filed 27 Jul 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code L | $7,03134 at $206.81 | filing |
| 22 Jul 2026filed 27 Jul 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code L | $7,03234 at $206.81 | filing |
| 20 Apr 2026filed 24 Apr 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code L | $7,20437 at $194.70 | filing |
| 20 Apr 2026filed 24 Apr 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code L | $7,20437 at $194.70 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $1.2M5,682 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $477K2,326 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $1.2M5,682 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $477K2,326 at $204.86 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $39K188 at $204.86 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $39K188 at $204.86 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —1,586 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $43K205 at $210.01 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $48K230 at $206.99 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —7,332 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —7,332 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —1,586 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $43K205 at $210.01 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $48K230 at $206.99 | filing |
News
No headline names them, or the companies they trade most, lately.